REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 27 filers reported holding REGULUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $193,000 | +4.3% | 649,070 | +10.2% | 0.00% | – |
| Q4 2021 | $185,000 | -60.0% | 589,196 | -12.2% | 0.00% | – |
| Q3 2021 | $463,000 | -3.3% | 670,747 | +13.8% | 0.00% | – |
| Q2 2021 | $479,000 | -19.5% | 589,196 | +54.3% | 0.00% | – |
| Q1 2021 | $595,000 | +591.9% | 381,892 | +493.5% | 0.00% | – |
| Q4 2020 | $86,000 | +160.6% | 64,347 | 0.0% | 0.00% | – |
| Q3 2020 | $33,000 | -23.3% | 64,347 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +48.3% | 64,347 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -74.6% | 64,347 | -50.0% | 0.00% | – |
| Q4 2019 | $114,000 | +147.8% | 128,694 | +100.0% | 0.00% | – |
| Q3 2019 | $46,000 | -42.5% | 64,347 | 0.0% | 0.00% | – |
| Q2 2019 | $80,000 | +95.1% | 64,347 | +59.6% | 0.00% | – |
| Q1 2019 | $41,000 | -44.6% | 40,327 | -50.0% | 0.00% | – |
| Q4 2018 | $74,000 | – | 80,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,851,851 | $951,000 | 0.11% |
| BVF INC/IL | 3,217,480 | $1,654,000 | 0.09% |
| NEA Management Company, LLC | 2,052,455 | $1,055,000 | 0.04% |
| McGuire Investment Group, LLC | 24,000 | $12,000 | 0.00% |
| WEDBUSH SECURITIES INC | 70,204 | $36,000 | 0.00% |
| GRIMES & COMPANY, INC. | 23,998 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,200 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 64,347 | $33,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 49,497 | $25,000 | 0.00% |